• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国一家大型三级保健中心的各种筛查方式下结直肠癌筛查的参与率和依从性:一项回顾性分析。

Colorectal cancer screening uptake and adherence by modality at a large tertiary care center in the United States: a retrospective analysis.

机构信息

Department of Medicine, Duke University Medical Center, Durham, NC, USA.

Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA.

出版信息

Curr Med Res Opin. 2024 Mar;40(3):431-439. doi: 10.1080/03007995.2024.2303090. Epub 2024 Jan 22.

DOI:10.1080/03007995.2024.2303090
PMID:38197407
Abstract

OBJECTIVE

Real-world data is crucial to inform existing opportunistic colorectal cancer (CRC) prevention programs. This study aimed to assess CRC screening adherence and utilization of various screening modalities within a Primary Care network over a three-year period (2017-2019).

METHODS

A retrospective review of individuals aged 50-75 years at average CRC risk, with at least one clinic visit in the previous 24 months. The primary outcome, CRC screening adherence (overall and by modality) was examined among the entire eligible population and newly adherent individuals each calendar year. The final sample included 107,366 patients and 218,878 records.

RESULTS

Overall CRC screening adherence increased from 71% in 2017 to 78% in 2019. For "up-to-date" individuals, colonoscopy was the predominant modality (accounting for approximately 74%, versus 4% of adherence for non-invasive options). However, modality utilization trends changed over time in these individuals: mt-sDNA increased 10.2-fold, followed by FIT (1.6-fold) and colonoscopy (1.1-fold). Among newly adherent individuals, the proportion screened by colonoscopy and FOBT decreased over time (89% to 80% and 2.4% to 1.2%, respectively), while uptake of FIT and mt-sDNA increased (7.7% to 11.5% and 0.9% to 6.8%, respectively). Notably, FIT and mt-sDNA increases were most evident in age and race-ethnicity groups with the lowest screening rates.

CONCLUSIONS

In an opportunistic CRC screening program, adherence increased but remained below the national 80% goal. While colonoscopy remained the most utilized modality, new colonoscopy uptake declined, compared with rising mt-sDNA and FIT utilization. Among minority populations, new uptake increased most with mt-sDNA and FIT.

摘要

目的

真实世界的数据对于现有机会性结直肠癌(CRC)预防计划至关重要。本研究旨在评估在三年期间(2017-2019 年),初级保健网络中 CRC 筛查的依从性和各种筛查方式的利用情况。

方法

对平均 CRC 风险为 50-75 岁且在过去 24 个月内至少有一次就诊的个体进行回顾性审查。在整个合格人群中以及每年新符合条件的个体中,检查 CRC 筛查的依从性(总体和按方式)。最终样本包括 107366 名患者和 218878 条记录。

结果

总体 CRC 筛查的依从性从 2017 年的 71%增加到 2019 年的 78%。对于“最新”的个体,结肠镜检查是主要的方式(占约 74%,而非侵入性选择的依从性为 4%)。然而,在这些个体中,模式利用趋势随时间而变化:mt-sDNA 增加了 10.2 倍,其次是 FIT(1.6 倍)和结肠镜检查(1.1 倍)。在新符合条件的个体中,结肠镜检查和 FOBT 的筛查比例随时间降低(分别从 89%降至 80%和从 2.4%降至 1.2%),而 FIT 和 mt-sDNA 的使用率增加(分别从 7.7%升至 11.5%和从 0.9%升至 6.8%)。值得注意的是,在筛查率最低的年龄和种族群体中,FIT 和 mt-sDNA 的使用率增加最为明显。

结论

在机会性 CRC 筛查计划中,依从性增加,但仍低于全国 80%的目标。虽然结肠镜检查仍然是最常用的方式,但与 mt-sDNA 和 FIT 的使用增加相比,新的结肠镜检查使用率下降。在少数民族群体中,mt-sDNA 和 FIT 的新使用率增加最多。

相似文献

1
Colorectal cancer screening uptake and adherence by modality at a large tertiary care center in the United States: a retrospective analysis.美国一家大型三级保健中心的各种筛查方式下结直肠癌筛查的参与率和依从性:一项回顾性分析。
Curr Med Res Opin. 2024 Mar;40(3):431-439. doi: 10.1080/03007995.2024.2303090. Epub 2024 Jan 22.
2
Healthcare costs, resource utilization, and productivity loss associated with colorectal cancer screening.与结直肠癌筛查相关的医疗保健成本、资源利用和生产力损失。
Expert Rev Pharmacoecon Outcomes Res. 2023 Jul-Dec;23(7):843-852. doi: 10.1080/14737167.2023.2220965. Epub 2023 Jul 18.
3
Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes.基于粪便的结直肠癌筛查和阳性检测后结肠镜检查中患者依从性对临床结局的影响。
Cancer Prev Res (Phila). 2021 Sep;14(9):845-850. doi: 10.1158/1940-6207.CAPR-21-0075. Epub 2021 May 21.
4
Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.分析两种用于筛查普通风险成年人结直肠癌的非侵入性粪便检测的有效性。
Public Health. 2020 May;182:70-76. doi: 10.1016/j.puhe.2020.01.021. Epub 2020 Mar 13.
5
Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.多靶点粪便 DNA 检测筛查结直肠肿瘤的有效性和成本效益比较。
Gastroenterology. 2016 Sep;151(3):427-439.e6. doi: 10.1053/j.gastro.2016.06.003. Epub 2016 Jun 14.
6
Projecting total costs and health consequences of increasing mt-sDNA utilization for colorectal cancer screening from the payer and integrated delivery network perspectives.从支付方和综合交付网络角度预测增加 mt-sDNA 在结直肠癌筛查中的应用的总费用和健康后果。
J Med Econ. 2020 Jun;23(6):581-592. doi: 10.1080/13696998.2020.1730123. Epub 2020 Apr 11.
7
Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population.基于粪便的结直肠癌筛查在医疗保险人群中的真实世界成本效益分析。
J Med Econ. 2021 Jan-Dec;24(1):654-664. doi: 10.1080/13696998.2021.1922240.
8
Lowering the colorectal cancer screening age improves predicted outcomes in a microsimulation model.降低结直肠癌筛查年龄可改善微观模拟模型预测的结果。
Curr Med Res Opin. 2021 Jun;37(6):1005-1010. doi: 10.1080/03007995.2021.1908244. Epub 2021 Apr 16.
9
The cost-effectiveness of non-invasive stool-based colorectal cancer screening offerings from age 45 for a commercial and medicare population.45 岁及以上商业和医疗保险人群非侵入性基于粪便的结直肠癌筛查产品的成本效益。
J Med Econ. 2023 Jan-Dec;26(1):1219-1226. doi: 10.1080/13696998.2023.2260681. Epub 2023 Oct 6.
10
Utilization of a Colorectal Cancer Screening Test Among Individuals With Average Risk.普通风险人群的结直肠癌筛查试验利用情况。
JAMA Netw Open. 2021 Sep 1;4(9):e2122269. doi: 10.1001/jamanetworkopen.2021.22269.

引用本文的文献

1
Adherence to multi-target stool DNA colorectal cancer screening and clinical follow-up in the Hartford HealthCare system.哈特福德医疗保健系统中多靶点粪便DNA结肠癌筛查及临床随访的依从性
Int J Colorectal Dis. 2025 Sep 16;40(1):200. doi: 10.1007/s00384-025-04997-5.
2
Adherence to Repeat Screening Completion for Colorectal Cancer Using the Multi-Target Stool DNA Test: Real-World Analysis of Patients from Federally Qualified Health Centers.使用多靶点粪便DNA检测坚持完成结直肠癌重复筛查:对来自联邦合格健康中心患者的真实世界分析
J Prim Care Community Health. 2025 Jan-Dec;16:21501319251348099. doi: 10.1177/21501319251348099. Epub 2025 Jun 17.
3
Impact of Spanish Language Outreach on Multi-Target Stool DNA Test Adherence in a Federally Qualified Health Center in the United States.
西班牙语言推广对美国一家联邦合格医疗中心多靶点粪便DNA检测依从性的影响
Cancer Control. 2025 Jan-Dec;32:10732748251343334. doi: 10.1177/10732748251343334. Epub 2025 May 14.
4
Is the development of liquid biopsy for the early detection and the monitoring of breast cancers on its way of overtaking mammography?液体活检用于乳腺癌早期检测和监测的发展是否即将超越乳房X线摄影术?
Front Med (Lausanne). 2024 Aug 9;11:1415940. doi: 10.3389/fmed.2024.1415940. eCollection 2024.
5
Trends in Colorectal Cancer Screening from the National Health Interview Survey: Analysis of the Impact of Different Modalities on Overall Screening Rates.国家健康访谈调查中的结直肠癌筛查趋势:不同方式对总体筛查率影响的分析。
Cancer Prev Res (Phila). 2024 Jun 4;17(6):275-280. doi: 10.1158/1940-6207.CAPR-23-0443.